查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654284

肾功能检测市场规模、份额、趋势分析报告：按产品、最终用途、地区、细分市场预测，2025-2030 年

Kidney Function Tests Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

肾功能测试市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球肾功能检测市场规模预计到2030年将达到13.9亿美元，2025年至2030年期间的复合年增长率为6.7%。

肾臟疾病高发、研发活动活性化、市场参与企业的投资不断增加以及技术创新等关键因素预计将显着推动市场成长。此外，政府采取越来越多的倡议提供各种便利，例如诊断测试报销，也可能成为推动市场发展的主要因素。

工业公司引入创新的肾功能测试正在增加这些诊断测试的采用。例如，2022 年 12 月，Journey Biosciences, Inc.推出了其主打产品 NaviDKD。这是一项基于生物标记的血液测试，可以在症状出现前几年评估糖尿病患者患肾臟病的风险。与取得专利的指南针彙报平台结合，该产品提供了可操作的见解，以管理和预防併发症的发生。预计此类发展将在预测期内推动市场发展。

此外，预计预测期内新产品开发的研发倡议将显着推动市场成长。例如，2021年2月，德比和伯顿大学医院、NHS基金会信託和诺丁汉大学的研究人员获得了232万美元的资助，用于帮助改善肾臟疾病的治疗和诊断。调查团队计划使用多参数 MRI 扫描来评估患有 CKD 的患者。同样，加拿大肾臟研究组织也获得了 1,180 万美元的新投资，以支持其 2027 年的活动。 Can-SOLVE慢性肾臟病网络是加拿大有史以来最大的肾臟研究倡议。

COVID-19 疫情导致全国住院人数增加和感染热点增加。截至 2021 年 6 月，全球已出现至少三波新冠肺炎疫情，对医院资源带来巨大压力，尤其是人力和透析设备和用品的可用性。此外，新冠肺炎疫情也影响了肾臟病患者的医疗保健服务。保持社交距离和门锁成为世界各地的常态，导致其他卫生服务暂时关闭。疫情期间，由于非紧急咨询和检测服务被暂停，多种肾臟疾病的诊断也被推迟。

此外，预计研究期间肾臟疾病发生率的不断上升将增加对诊断测试的需求。例如，根据美国国家肾臟基金会的数据，美国约有 3,700 万人（即超过七分之一的成年人）患有某种形式的肾臟疾病。同样，根据FDA发布的资料，美国每年约有10,000名儿童患有急性肾损伤（AKI）。这些孩子的存活率约为38%至43%。患有 AKI 的新生儿死亡率约为 60%。这些因素预计将促进新生儿血液透析机的需求并推动市场成长。

然而，对肾臟疾病的认识低预计会阻碍市场的成长。例如，据估计，美国约有 3700 万成年人患有肾臟疾病，但约 90% 的人并不知道自己患有这种疾病。肾臟疾病的主要危险因子是高血压、糖尿病、心臟病、肥胖和家族病史。然而，各政府机构已经启动计画来提高人们对肾功能测试的认识。例如，截至 2020 年 3 月，泰米尔纳德邦肾臟研究基金会已进行了 1,279 次宣传活动。

肾功能检测市场报告重点

  • 根据产品，清关检查部分占据最大的市场份额。这些测试提供最佳的灵敏度和精确度，以最大限度地减少性能变化。由于其成本低廉且随时可用，所以其采用率越来越高。
  • 根据最终用途，由于 CKD 盛行率不断上升导致对体外诊断 (IVD) 测试的需求不断增长，医院部门预计将在 2024 年占据市场占有率。
  • 由于完善的医疗保健基础设施、健全的报销政策和政府倡议，北美在 2024 年占据了全球市场的主导地位。
  • 由于中国和印度等新兴经济体针对 CKD 的宣传活动不断增多，预计亚太地区未来将显着成长。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 肾功能检测市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 肾功能检测市场分析工具
    • 产业分析-波特五力分析
    • PESTEL 分析

第四章 肾功能检测市场：产品评估与趋势分析

  • 2024 年及 2030 年产品市场占有率
  • 细分仪表板
  • 全球肾功能检测市场（按产品）展望
  • 2018 年至 2030 年市场规模、预测及趋势分析
    • 清除测试
    • 血液检查
    • 尿液检查
    • 稀释和浓度测试
    • 其他测试

第 5 章肾功能检测市场：最终用途估计与趋势分析

  • 2024 年及 2030 年终端用途市场占有率
  • 细分仪表板
  • 全球肾功能检测市场前景（依最终用途）
  • 2018 年至 2030 年市场规模、预测及趋势分析
    • 医院
    • 诊断实验室
    • 研究室和实验室
    • 其他的

第六章肾功能检测市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018 年至 2030 年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • Key company market share analysis, 2024
    • Danaher
    • Danaher
    • F. Hoffmann-La Roche Ltd
    • Sysmex Corporation
    • Siemens Healthineers
    • Randox Laboratories Ltd
    • Quest Diagnostics
    • Acon Laboratories, Inc
    • Nova Biomedical Corporation
    • Laboratory Corporation Of America Holdings
Product Code: GVR-1-68038-721-6

Kidney Function Tests Market Growth & Trends:

The global kidney function tests market size is expected to reach USD 1.39 billion by 2030, registering at a CAGR of 6.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key factors such as high prevalence of kidney diseases, the rising R&D activities, increasing investments by market players, and technological innovations are anticipated to significantly drive the market growth. Moreover, the growing number of initiatives undertaken by the government to provide various facilities, such as reimbursement for diagnostic tests is a major factor likely to boost the market.

Introduction of innovative kidney function tests in the market by the operating players is increasing the adoption of these diagnostics tests. For instance, in December 2022, Journey Biosciences, Inc. launched its leading product-NaviDKD. It is a biomarker-based blood test, which evaluates the peril of renal disease in people with diabetes years before the symptoms appear. Along with its patented compass reporting platform, the product provides actionable insights for managing and preventing complications before they arise. Such developments are foreseen to fuel the market during the forecast period.

Furthermore, rising R&D initiatives for the development of novel products are expected to significantly fuel the market growth during the forecast period. For instance, in February 2021, Researchers from the University Hospitals of Derby and Burton, NHS Foundation Trust, and the University of Nottingham received USD 2.32 million in funding to help improve the treatment and diagnosis of renal diseases. Researchers will use multi-parametric MRI scanning to evaluate patients suffering from CKD. Similarly, the Canadian kidney research organization received a new USD 11.8 million investment to support its work through 2027. The Can-SOLVE Chronic Kidney Disease Network is the largest-ever kidney research initiative in Canada.

The COVID-19 pandemic has been associated with increase in hospitalization and infection hotspots around the country. There were at least three separate waves of COVID-19 around the world by June 2021 that put a significant strain on hospital resources, especially labor and availability of dialysis equipment & supplies. In addition, the COVID-19 pandemic has affected healthcare services for renal disease patients. Social distancing and lockdown were mandate norms, globally, leading to temporary closure of other medical services. The diagnosis of several renal diseases deferred during the pandemic due to suspension of non-urgent visits and testing services.

Moreover, the growing prevalence of renal diseases is projected to increase the demand for diagnostic tests during the study period. For instance, according to The National Kidney Foundation, Inc., an estimated 37 million people in the U.S., i.e., more than one in seven adults, are living with some form of renal disease. Similarly, according to data published by FDA, about 10,000 children in the U.S. develop acute kidney infections (AKI) every year. These children possess a survival rate of around 38%-43%. The mortality rate for neonates with AKI is around 60%. Such factors are likely to drive the demand for neonatal hemodialysis, thereby driving the market growth.

On the other hand, low awareness regarding renal diseases is expected to hamper the market growth. For instance, In the U.S., an estimated 37 million adults have kidney disease and about 90% remain unaware of the condition. Major risk factors for the disease are high blood pressure and diabetes as well as heart disease, obesity, & family history of kidney disease. However, various government bodies are initiating programs for raising awareness of kidney function tests. For instance, Tamilnadu Kidney Research Foundation has conducted 1,279 awareness programs until March 2020.

Kidney Function Tests Market Report Highlights:

  • By product, the clearance tests segment held the largest share of the market. These tests ensure that there is minimal variation in performance owing to their optimum sensitivity and precision. The low cost and easy availability of these products in the market lead to their increased adoption.
  • By end-user, the hospitals segment accounted for the dominant market share in 2024, due to the rising demand for IVD tests because of increase in the prevalence of CKD.
  • North America dominated the global market in 2024 due to the well-established healthcare infrastructure, favorable reimbursement policies and government initiatives in the region.
  • Asia Pacific is expected to grow considerably in the future owing to the increasing awareness programs about CKD in emerging economies, such as China & India.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End use
    • 1.2.3. Application
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Kidney Function Tests Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Introduction Of Innovative Kidney Function Tests
      • 3.2.1.2. Increasing Investments In R&D
      • 3.2.1.3. Increasing Prevalence Of Acute Kidney Injury And Associated Chronic Kidney Disease
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Low Awareness Regarding Kidney Diseases
  • 3.3. Kidney Function Tests Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Kidney Function Tests Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Kidney Function Tests Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Clearance Tests
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 4.4.2. Blood Tests
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Urine Tests
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Dilution & Concentration Tests
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Other Tests
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Kidney Function Tests Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Kidney Function Tests Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Diagnostic Laboratories
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Research Laboratories And Institutes
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Kidney Function Tests Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2024
    • 7.3.2. Danaher
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Danaher
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. F. Hoffmann-La Roche Ltd
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Sysmex Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Siemens Healthineers
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Randox Laboratories Ltd
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Quest Diagnostics
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Acon Laboratories, Inc
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Nova Biomedical Corporation
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Laboratory Corporation Of America Holdings
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives

List of Tables

  • Table 1 Premarket approval process
  • Table 2 Key companies adopting expansion strategy
  • Table 3 Key companies adopting collaboration strategy
  • Table 4 Key companies launching new products/services
  • Table 5 Key companies adopting partnership strategy
  • Table 6 List of Secondary Sources
  • Table 7 List of Abbreviations
  • Table 8 Global Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 9 Global Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10 Global Kidney Function Tests Market, by Region, 2018 - 2030 (USD Million)
  • Table 11 North America Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
  • Table 12 North America Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 North America Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 14 U.S Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 U.S Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 16 Canada Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 17 Canada Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 18 Mexico Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Mexico Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 20 Europe Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 22 Europe Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 23 Germany Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Germany Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 25 UK Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 UK Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 27 France Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 28 France Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 Italy Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 30 Italy Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 31 Spain Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Spain Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 33 Denmark Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 34 Denmark Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 35 Sweden Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 Sweden Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 37 Norway Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 38 Norway Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Japan Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Japan Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 44 China Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 45 China Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 46 India Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 India Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 48 South Korea Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 South Korea Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 50 Australia Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Australia Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 52 Singapore Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 53 Singapore Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 54 Thailand Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Thailand Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 56 Latin America Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
  • Table 57 Latin America Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 Latin America Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 59 Brazil Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Brazil Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 61 Argentina Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 62 Argentina Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 63 Middle East & Africa Kidney Function Tests Market, by Country, 2018 - 2030 (USD Million)
  • Table 64 Middle East & Africa Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 65 Middle East & Africa Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 66 South Africa Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 South Africa Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 68 Saudi Arabia Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 Saudi Arabia Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 UAE Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 UAE Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)
  • Table 72 Kuwait Kidney Function Tests Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Kuwait Kidney Function Tests Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Executives contacted
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Kidney function tests market estimation process
  • Fig. 10 Market snapshot
  • Fig. 11 Market segmentation and scope
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Market drivers impact
  • Fig. 16 Reported causes of end-stage renal disease in the U.S.
  • Fig. 17 Percentage of U.S. adults aged 18 or older with CKD
  • Fig. 18 Market restraint relevance analysis (Current & future impact)
  • Fig. 19 Kidney function test market: product outlook and key takeaways
  • Fig. 20 Kidney function tests market: product movement analysis
  • Fig. 21 Clearance tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Blood tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Urine tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Dilution & concentration tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Other tests market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Kidney function test market: end-use outlook and key takeaways
  • Fig. 27 Kidney function test market: end-use movement analysis
  • Fig. 28 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Research laboratories and institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Regional marketplace: key takeaways
  • Fig. 33 North America kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 France kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 India kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Singapore kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 UAE kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait kidney function tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Market participant categorization
  • Fig. 63 Kidney function tests market share analysis, 2024
  • Fig. 64 Strategic framework